まとめ
アパミンは蜂の毒の神経毒素で,滑らかな筋肉のATP誘発のカリウムチャネル活動を阻害する. この発見は,アパミンが特定のATP受容体ブロッカーではなく,むしろカリウムの浸透性の変化を抑制することを示唆しています.
科学分野:
- 神経薬理学神経薬理学について
- 滑らかな筋肉の生理学 滑らかな筋肉の生理学
- ミツバチの毒の研究
背景:
- アパミンは,蜂の毒から得られた神経毒性ポリペプチドで,構造は知られている.
- 以前の研究では,ATPは,内臓の滑らかな筋肉への非アドレナージック阻害性神経供給における神経伝達物質であると示唆されていました.
- アパミンは,この purinergic 阻害の特定のポストシナプスブロックとして暫定的に特定されました.
研究 の 目的:
- アパミンが内臓の滑らかな筋肉に及ぼす作用のメカニズムを調査する.
- アパミンがATP媒介阻害のための特定のポストシナプス阻害剤として作用するかどうかを決定する.
- アパミンの非アドレナergic, purinergic 阻害における役割を明確にするために.
主な方法:
- アパミンのATPへの作用と神経刺激誘発阻害の実験的確認.
- アパミンがカリウムの浸透性に与える影響の調査.
- アパミンのナノモラー濃度を用いて,内臓の滑らかな筋肉の製剤 (豚の胃,大腸菌) を利用した.
主要な成果:
- ナノモラー濃度のアパミンは,外部から施されたATPと非アドレネルジック神経刺激の両方による抑制を減少させます.
- アパミンは,ATPによって誘発されるカリウム浸透性の増加を抑制することが判明しました.
- この結果は,アパミンの作用がATP受容体に特異的ではないことを示唆している.
結論:
- アパミンは,ATPおよび他の作用因子によって引き起こされるカリウムの浸透性の増加を抑制します.
- アパミンはATP受容体の特定のポストシナプスブロックではありません.
- アパミンのポタシウム透過性に対するより広範な効果は,非アドレナergic,purinergicの滑らかな筋肉の抑制に対する抑制作用の基礎となっています.
さらに関連する動画
関連する概念動画
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...